Improving the metabolic fidelity of cancer models with a physiological cell culture medium

Johan Vande Voorde(Cancer Research UK Scotland Institute), Tobias Ackermann(Cancer Research UK Scotland Institute), Nadja Pfetzer(Cancer Research UK Scotland Institute), David Sumpton(Cancer Research UK Scotland Institute), Gillian Mackay(Cancer Research UK Scotland Institute), Gabriela Kalna(Cancer Research UK Scotland Institute), Colin Nixon(Cancer Research UK Scotland Institute), Karen Blyth(Cancer Research UK Scotland Institute), Eyal Gottlieb(Technion – Israel Institute of Technology), Saverio Tardito(Cancer Research UK Scotland Institute)
Science Advances
January 2, 2019
Cited by 408Open Access
Full Text

Abstract

Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabolic artifacts on cancer cells. Their supraphysiological concentrations of pyruvate stabilize hypoxia-inducible factor 1α in normoxia, thereby inducing a pseudohypoxic transcriptional program. In addition, their arginine concentrations reverse the urea cycle reaction catalyzed by argininosuccinate lyase, an effect not observed in vivo, and prevented by Plasmax in vitro. The capacity of cancer cells to form colonies in commercial media was impaired by lipid peroxidation and ferroptosis and was rescued by selenium present in Plasmax. Last, an untargeted metabolic comparison revealed that breast cancer spheroids grown in Plasmax approximate the metabolic profile of mammary tumors better. In conclusion, a physiological medium improves the metabolic fidelity and biological relevance of in vitro cancer models.


Related Papers

No related papers found

Powered by citation graph analysis